RSNA 2020 Artificial Intelligence Preview

VUNO to showcase power of flagship AI solution at RSNA

By VUNO

November 9, 2020 -- VUNO will attend RSNA 2020 to showcase the power of its flagship artificial intelligence (AI) radiology solutions, which have received the CE Mark and are currently being evaluated by the U.S. Food and Drug Administration under the 510(k) process.

As part of its ambitious plan to go global, VUNO is set to seize the opportunity of RSNA 2020 to further expand its networks with sales prospects and business partners from all around the world.

VUNO's exhibits at the RSNA show include the following:

  • VUNO Med-LungCT AI, which detects, characterizes, and quantifies pulmonary lung nodules on CT images
  • VUNO Med-Chest X-ray, which assists in the chest x-ray readings of common thoracic abnormalities on chest radiographs
  • VUNO Med-DeepBrain, which is a supporting diagnostic tool for degenerative brain diseases through brain parcellation and quantification on brain MR images
  • VUNO Med-BoneAge, which serves as an auxiliary diagnostic software to read children's bone age by automatically providing three reference images that most closely match the patient's

VUNO's AI solutions are reshaping the medical industry, presenting a whole new level of experience to medical practitioners in their day-to-day workflow and enabling them to make diagnostic decisions faster and more accurately and provide quality patient care.

We are on a mission to "View the Invisible, Know the Unknown," and we will never rest until we discover the invisible and unknown territories of medicine by navigating ambiguity with the help of artificial intelligence.

VUNO will highlight its lineup of AI solutions at RSNA 2020
VUNO will highlight its lineup of AI solutions at RSNA 2020.

Copyright © 2020 AuntMinnie.com

Last Updated bc 11/5/2020 12:17:32 PM